Monthly: Fate Therapeutics (FATE: $2.51) shares post worst month in seven months

Press/Media: Press / Media

PeriodSep 1 2023

Media coverage

1

Media coverage

  • TitleMonthly: Fate Therapeutics (FATE: $2.51) shares post worst month in seven months
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date9/1/23
    PersonsMichael Lee
View all 1
View less